121.55
前日終値:
$123.05
開ける:
$123.4
24時間の取引高:
684.16K
Relative Volume:
0.85
時価総額:
$8.69B
収益:
$12.82B
当期純損益:
$936.34M
株価収益率:
11.32
EPS:
10.74
ネットキャッシュフロー:
$1.47B
1週間 パフォーマンス:
-1.73%
1か月 パフォーマンス:
-4.00%
6か月 パフォーマンス:
-13.12%
1年 パフォーマンス:
-21.26%
Davita Inc Stock (DVA) Company Profile
DVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
121.55 | 8.69B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
472.65 | 108.00B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
192.91 | 17.28B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.39 | 13.74B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
225.04 | 14.22B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
113.46 | 11.50B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
How DaVita Inc. (TRL) stock expands through international marketsJuly 2025 Update & Daily Chart Pattern Signals - newser.com
Sentiment analysis tools applied to DaVita Inc.Trade Ideas & Free Safe Entry Trade Signal Reports - newser.com
DaVita Inc.’s volatility index tracking explainedJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Is DaVita Inc. stock bottoming outTrade Risk Report & Safe Entry Point Identification - newser.com
Why DaVita Inc. stock stays on buy listsRecession Risk & Weekly High Potential Stock Alerts - newser.com
DaVita Inc. to Participate in Fireside Chat with Wolfe Research - The Malaysian Reserve
Has DaVita Inc. formed a bullish divergenceWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com
Will DaVita Inc. stock outperform tech sector in 2025Weekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Is a relief rally coming for DaVita Inc. holders2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Using AI based signals to follow DaVita Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks - Yahoo Finance
DaVita's New Kidney Research Unveiling Might Change The Case For Investing In DVA - Yahoo Finance
Can DaVita Inc. (TRL) stock retain market dominanceJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Is DaVita Inc. (TRL) stock testing key supportFed Meeting & Advanced Technical Analysis Signals - newser.com
Technical analysis overview for DaVita Inc. stockRate Hike & Precise Swing Trade Entry Alerts - newser.com
Can DaVita Inc. (TRL) stock attract ESG investments2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Jim Cramer Discusses DaVita’s (DVA) Share Price Movement - MSN
ROCKWELL MEDICAL, INC. SEC 10-Q Report - TradingView
DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains - 富途牛牛
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know - Yahoo Finance
DaVita Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
DaVita Inside: Expansion of At-Home Dialysis & Sustained ESRD Patient Growth To Shape The Future in Kidney Care! - Smartkarma
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Will DaVita Inc. rebound enough to break evenEarnings Recap Report & Low Risk Profit Maximizing Plans - newser.com
Is DaVita Inc. stock safe for conservative investorsEntry Point & Low Risk Entry Point Tips - newser.com
DaVita Stock: Analyst Estimates & Ratings - Barchart.com
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
Davita Inc (DVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jul 31 '25 |
Sale |
140.61 |
1,635,962 |
230,024,764 |
32,160,579 |
| HEARTY JAMES O | Chief Compliance Officer |
Jul 23 '25 |
Sale |
150.00 |
2,351 |
352,650 |
26,038 |
大文字化:
|
ボリューム (24 時間):